DENTSPLY SIRONA Inc.
XRAYNASDAQHealthcare● Active
$10.18
+$0.18(+1.80%)
Market Cap$2.0B
P/E Ratio—
52W High$17.09
52W Low$9.41
DENTSPLY SIRONA Inc. (XRAY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
XRAY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.27
Est. $0.28 · -3.6%
Revenue
$0.88B
Est. $0.84B · +4.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
XRAY reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.36 | — | — | — | $0.89B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.28 | $0.27 | -3.6% | $0.88B | $0.84B | +4.5% |
| ▼ Q1 FY2026 | Feb 26, 2026 | $0.28 | $0.27 | -3.6% | $0.96B | $0.93B | +3.8% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.45 | $0.37 | -17.8% | $0.90B | $0.93B | -2.5% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.50 | $0.52 | +4.0% | $0.94B | $0.90B | +3.5% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.29 | $0.43 | +48.3% | $0.88B | $0.92B | -4.5% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.47 | $0.26 | -44.7% | $0.91B | $0.90B | +0.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.48 | $0.50 | +4.2% | $0.95B | $0.94B | +1.5% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.36
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
$0.27
EPS Est.
$0.28
EPS Surpr.
-3.6%
Revenue
$0.88B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
$0.27
EPS Est.
$0.28
EPS Surpr.
-3.6%
Revenue
$0.96B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.37
EPS Est.
$0.45
EPS Surpr.
-17.8%
Revenue
$0.90B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.50
EPS Surpr.
+4.0%
Revenue
$0.94B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.43
EPS Est.
$0.29
EPS Surpr.
+48.3%
Revenue
$0.88B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
$0.26
EPS Est.
$0.47
EPS Surpr.
-44.7%
Revenue
$0.91B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.50
EPS Est.
$0.48
EPS Surpr.
+4.2%
Revenue
$0.95B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.53 | $0.55 | $0.56 | 5 |
| Q3 FY2028 | $0.42 | $0.42 | $0.44 | 10 |
| Q2 FY2028 | $0.41 | $0.42 | $0.43 | 7 |
| Q1 FY2028 | $0.35 | $0.36 | $0.37 | 5 |
| Q4 FY2027 | $0.45 | $0.46 | $0.47 | 4 |
| Q3 FY2027 | $0.40 | $0.41 | $0.42 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.0B | $1.0B | $1.0B | 4 |
| Q3 FY2028 | $0.9B | $0.9B | $0.9B | 4 |
| Q2 FY2028 | $0.9B | $0.9B | $1.0B | 4 |
| Q1 FY2028 | $0.9B | $0.9B | $0.9B | 4 |
| Q4 FY2027 | $1.0B | $1.0B | $1.0B | 5 |
| Q3 FY2027 | $0.9B | $0.9B | $0.9B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -3.6% | $11.20 | $11.37 | +1.52% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -3.6% | $12.80 | $12.71 | -0.70% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -17.8% | $12.62 | $11.02 | -12.68% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +4.0% | $13.68 | $13.23 | -3.29% |
| ▲ Q2 FY2025 | May 8, 2025 | +48.3% | $13.68 | $15.91 | +16.30% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -44.7% | $18.81 | $17.15 | -8.83% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +4.2% | $23.98 | $17.26 | -28.02% |
| ▼ Q3 FY2024 | Jul 31, 2024 | -2.0% | $26.78 | $27.14 | +1.34% |
Q2 FY2026+1.52%
Report Date
May 5, 2026
EPS Beat/Miss
-3.6%
Price Before
$11.20
Price After
$11.37
Q1 FY2026-0.70%
Report Date
Feb 26, 2026
EPS Beat/Miss
-3.6%
Price Before
$12.80
Price After
$12.71
Q4 FY2025-12.68%
Report Date
Nov 6, 2025
EPS Beat/Miss
-17.8%
Price Before
$12.62
Price After
$11.02
Q3 FY2025-3.29%
Report Date
Aug 7, 2025
EPS Beat/Miss
+4.0%
Price Before
$13.68
Price After
$13.23
Q2 FY2025+16.30%
Report Date
May 8, 2025
EPS Beat/Miss
+48.3%
Price Before
$13.68
Price After
$15.91
Q1 FY2025-8.83%
Report Date
Feb 27, 2025
EPS Beat/Miss
-44.7%
Price Before
$18.81
Price After
$17.15
Q4 FY2024-28.02%
Report Date
Nov 7, 2024
EPS Beat/Miss
+4.2%
Price Before
$23.98
Price After
$17.26
Q3 FY2024+1.34%
Report Date
Jul 31, 2024
EPS Beat/Miss
-2.0%
Price Before
$26.78
Price After
$27.14
Avg Beat Reaction-5.00%
Avg Miss Reaction-3.87%
Beat Rate3 / 8 quarters
Largest Move-28.02% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: XRAY ends December
DENTSPLY SIRONA Inc. (XRAY) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.27 — missing the analyst consensus of $0.28 by -3.6%. The next XRAY earnings date is expected around September 1, 2026.
Each quarter, investors track XRAY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. XRAY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
XRAY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
XRAY earnings · 5 questionsDENTSPLY SIRONA Inc.'s next earnings report is expected around September 1, 2026. XRAY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; XRAY historically reports after market close (AMC).
XRAY earnings datewhen is XRAY earningsXRAY next earnings datewhen does XRAY report earningsXRAY earnings calendar
▸ Source: FMP · DENTSPLY SIRONA Inc. SEC filings · US GAAP · DENTSPLY SIRONA Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026